Chiesi Group and Statkraft, Europe's largest producer of renewable energy, have signed a major agreement to supply more than 30 Gigawatt-hours per year of renewable electricity lasting 10 years starting in 2024. With this Renewable Power Purchase Agreement (PPA), Chiesi on the one hand secures the…
Doing business in harmony with the environment that surrounds us, generating profit and, at the same time, contributing to the creation of shared value for the community, giving a positive push towards a future that really puts people at the centre, emphasising responsibility, transparency and…
With the publication of Chiesi's Sustainability Report, Maria Paola Chiesi, Chiesi's Vice Chair and Head of Shared Value & Sustainability, sheds light on the company's sustainability initiatives of the last year and their impact. Looking back to 2022, what highlights confirm for you that Chiesi…
Buildings are responsible for a considerable amount of global energy use, resource consumption and greenhouse gas emissions and significantly impact the health of our planet and its inhabitants. At Chiesi, we strive to improve the sustainability performances of all our sites. With our…
The story behind an exceptional partnership and innovative product By Ameya Phadke, Patients Non-Pharma Solutions Leader at Chiesi Group Earlier this year, Kaia COPD, a digital solution aimed at improving the quality of life for COPD patients, has been listed in the German DiGA directory as a…
Today, on World Health Day, we celebrate the right to good health for every person, everywhere. The theme for this year's World Health Day is "Health For All: Joining Forces for a Better Future," which highlights the importance of working together to achieve universal health coverage and better…
Recently, the European Parliament adopted its position on the revision of the EU’s legislative framework on fluorinated greenhouse gases (F-gases) emissions. Chiesi shares the climate objectives and ambitions of European policymakers and welcomes the robust discussion around the pharmaceutical uses…
Once again, Chiesi Group has been confirmed as the 1 st Italian pharmaceutical company and the 3 rd among the Italian companies in all segments, for patents applications, with a consolidated number of 42 first filings at the European Patent Office (EPO), according to the publication of the patenting…
Since 2017, March has been ‘B Corp Month’, dedicated to celebrating and raising awareness of a young, but already established global movement (the B Corp movement), born out of a revolutionary idea: using business as a force for good. For centuries, our society has been founded on a divisive,…
You are leaving the Chiesi Corp site to access another Chiesi site. Regulatory constraints and medical practices, as well as the information published on the site you are about to visit, may change from one country to another and may not comply with current Italian legislation on the subject.
You are about to leave our website and access an external site. By continuing, you agree to leave our site.
